DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,232,381 | +3.4% | 4,967 | 0.0% | 0.30% | +4.2% |
| Q2 2023 | $1,192,133 | -7.2% | 4,967 | -2.6% | 0.29% | -13.0% |
| Q1 2023 | $1,284,942 | -2.6% | 5,098 | +2.6% | 0.33% | -8.3% |
| Q4 2022 | $1,318,903 | +2.1% | 4,969 | -0.7% | 0.36% | -7.4% |
| Q3 2022 | $1,292,000 | +0.8% | 5,003 | -1.1% | 0.39% | +3.2% |
| Q2 2022 | $1,282,000 | -14.9% | 5,058 | -1.6% | 0.38% | -6.9% |
| Q1 2022 | $1,507,000 | -10.5% | 5,139 | +0.5% | 0.41% | -9.6% |
| Q4 2021 | $1,683,000 | +9.0% | 5,114 | +0.9% | 0.45% | -8.7% |
| Q3 2021 | $1,544,000 | +13.4% | 5,070 | 0.0% | 0.49% | +18.3% |
| Q2 2021 | $1,361,000 | +0.1% | 5,070 | -16.1% | 0.42% | -4.4% |
| Q1 2021 | $1,359,000 | +1.7% | 6,040 | +0.5% | 0.44% | +5.6% |
| Q4 2020 | $1,336,000 | -0.5% | 6,012 | -3.6% | 0.41% | -15.9% |
| Q3 2020 | $1,343,000 | +21.3% | 6,235 | -0.4% | 0.49% | +8.6% |
| Q2 2020 | $1,107,000 | +3.2% | 6,259 | -19.2% | 0.45% | -14.4% |
| Q1 2020 | $1,073,000 | -7.4% | 7,751 | +2.7% | 0.53% | -0.9% |
| Q4 2019 | $1,159,000 | +5.7% | 7,549 | -0.6% | 0.53% | -2.0% |
| Q3 2019 | $1,096,000 | +21.2% | 7,591 | +20.0% | 0.54% | 0.0% |
| Q2 2019 | $904,000 | +5.7% | 6,324 | -2.3% | 0.54% | +1.7% |
| Q1 2019 | $855,000 | +28.0% | 6,475 | 0.0% | 0.53% | +5.5% |
| Q4 2018 | $668,000 | -6.0% | 6,475 | -1.2% | 0.51% | +6.1% |
| Q3 2018 | $711,000 | +9.6% | 6,551 | -0.5% | 0.48% | -2.3% |
| Q2 2018 | $649,000 | +0.6% | 6,586 | 0.0% | 0.49% | -7.2% |
| Q1 2018 | $645,000 | +113.6% | 6,586 | +102.6% | 0.53% | +71.9% |
| Q4 2017 | $302,000 | – | 3,250 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |